《Synthesis and evaluation of new 1,2,4-oxadiazole based trans-acrylic acid derivatives as potential PPAR-α/γ dual agonists》 was written by Kaur, Paranjeet; Bhat, Zahid Rafiq; Bhat, Sana; Kumar, Rakesh; Kumar, Rajan; Tikoo, Kulbhushan; Gupta, Jeena; Khurana, Navneet; Kaur, Jaskiran; Khatik, Gopal L.. Formula: C7H4FN And the article was included in Bioorganic Chemistry in 2020. The article conveys some information:
New 1,2,4-oxadiazole-containing trans-cinnamic acids I (R = Ph, 2-MeOC6H4, 3-MeOC6H4, 4-FC6H4, 4-ClC6H4, 4-MeC6H4) were synthesized and evaluated as dual PPAR-α/γ agonists. Using AutoDock Vina, compounds I were identified as potential PPAR α/γ dual agonists comparable to PPAR γ agonist Pioglitazone on the basis of their affinity scores, in-silico toxicity and in-silico ADME properties. These compounds showed better calculated lipophilicity (iLogP), which was found to be from 0.92 to 3.19. Compounds I (R = Ph, 4-FC6H4) were found to be most potent on both PPAR α and γ receptors with EC50 of 0.07 ± 0.0006μM, 0.06 ± 0.0005μM and 0.781 ± 0.008μM, 3.29μM ± 0.03 resp. compared to pioglitazone having EC50 of 32.38 ± 0.2 and 38.03 ± 0.13 for both receptors. The in-vivo evaluation found to reduce the plasma glucose level and total cholesterol level significantly in diabetic rats compared to pioglitazone at 5 mg/kg/day dose for 7 days of treatment. Thus, trans-cinnamic acids I can be further developed as oral therapeutic agents for diabetic interventions as PPAR α/γ dual agonists. The experimental part of the paper was very detailed, including the reaction process of 4-Fluorobenzonitrile(cas: 1194-02-1Formula: C7H4FN)
4-Fluorobenzonitrile(cas: 1194-02-1) is used as chemical intermediate, solvent for perfumes and pharmaceuticals, stabilizer for chlorinated solvents, HPLC analysis, catalyst and component of transition-metal complex catalysts.Formula: C7H4FN
Referemce:
Nitrile – Wikipedia,
Nitriles – Chemistry LibreTexts